Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-Term Prognosis Value of Paravalvular Leak and Patient-Prosthesis Mismatch following Transcatheter Aortic Valve Implantation: Insight from the France-TAVI Registry.
Deharo P, Leroux L, Theron A, Ferrara J, Vaillier A, Jaussaud N, Porto A, Morera P, Gariboldi V, Iung B, Lefevre T, Commeau P, Gouysse M, du Chayla F, Glatt N, Cayla G, Le Breton H, Benamer H, Beurtheret S, Verhoye JP, Eltchaninoff H, Gilard M, Collet JP, Dumonteil N, Collart F, Modine T, Cuisset T; France-TAVI and STOP-AS Investigators. Deharo P, et al. J Clin Med. 2022 Oct 17;11(20):6117. doi: 10.3390/jcm11206117. J Clin Med. 2022. PMID: 36294438 Free PMC article.
Off-label use of prasugrel in stable coronary artery disease is associated with greater degree of platelet inhibition compared with use after acute coronary syndrome.
Cuisset T, Cayla G, Quilici J, Pankert M, Deharo P, Bonnet G, Grosdidier C, Beguin S, Morange P, Bonnet JL, Alessi MC. Cuisset T, et al. Among authors: deharo p. Int J Cardiol. 2013 Oct 3;168(3):2988-9. doi: 10.1016/j.ijcard.2013.04.052. Epub 2013 Apr 30. Int J Cardiol. 2013. PMID: 23642612 No abstract available.
Timing of Angiography and Outcomes in High-Risk Patients With Non-ST-Segment-Elevation Myocardial Infarction Managed Invasively: Insights From the TAO Trial (Treatment of Acute Coronary Syndrome With Otamixaban).
Deharo P, Ducrocq G, Bode C, Cohen M, Cuisset T, Mehta SR, Pollack C Jr, Wiviott SD, Elbez Y, Sabatine MS, Steg PG. Deharo P, et al. Circulation. 2017 Nov 14;136(20):1895-1907. doi: 10.1161/CIRCULATIONAHA.117.029779. Epub 2017 Sep 11. Circulation. 2017. PMID: 28893843 Clinical Trial.
Benefit of Switching Dual Antiplatelet Therapy After Acute Coronary Syndrome According to On-Treatment Platelet Reactivity: The TOPIC-VASP Pre-Specified Analysis of the TOPIC Randomized Study.
Deharo P, Quilici J, Camoin-Jau L, Johnson TW, Bassez C, Bonnet G, Fernandez M, Ibrahim M, Suchon P, Verdier V, Fourcade L, Morange PE, Bonnet JL, Alessi MC, Cuisset T. Deharo P, et al. JACC Cardiovasc Interv. 2017 Dec 26;10(24):2560-2570. doi: 10.1016/j.jcin.2017.08.044. JACC Cardiovasc Interv. 2017. PMID: 29268886 Free article. Clinical Trial.
84 results